chartexchange

NPCE
Neuropace, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:52 PM EST
8.22USD+0.183%(+0.02)307,368
After-hoursNov 18, 2026 4:00:30 PM EST
8.22USD+0.061%(+0.01)
Loading…
Loading…
283.02M
Healthcare
Medical Devices
HQ
Mountain View, CA, USA
Previous Close
$8.20
Beta
1.32
52-Week High
$19.60 2026-05-08
52-Week Low
$5.46 2026-11-13
SMA 50
$12.94
SMA 200
$14.69
Avg. Vol 10D
966,014
Avg. Vol 30D
392,033
Avg. Vol 90D
245,020
Relative Vol
0.78
25.70M
0.4800%
531
NPCE Profile

the rns® system is an award-winning technology developed and manufactured in silicon valley that has been recognized for its innovation. similar to a pacemaker that monitors and responds to heart rhythms, the rns system is the world's first and only medical device that can monitor and respond to brain activity. neuropace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation. the company's initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.in addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world.

NPCE Performance
PeriodPriceDateChangeBeta
1W12.522026-11-11-34.38%-17.430
1M12.772026-10-19-35.67%1.249
3M14.472026-08-18-43.23%1.259
6M15.992026-05-18-48.62%1.187
1Y13.022025-11-18-36.91%1.325
2Y8.952024-11-18-8.21%—
5Y11.442021-11-18-28.19%0.950
NPCE Stock Summary

Neuropace, Inc. Common Stock (NASDAQ:NPCE) stock price today is $8.22, and today's volume is 307,368. NPCE is up 0.183% today. The 30 day average volume is 392,033. NPCE market cap is $283.02M with 34.45M shares outstanding.